[go: up one dir, main page]

Ye et al., 2020 - Google Patents

Exosomes transmit viral genetic information and immune signals may cause immunosuppression and immune tolerance in ALV-J infected HD11 cells

Ye et al., 2020

View HTML
Document ID
11794067660354415777
Author
Ye F
Wang Y
He Q
Cui C
Yu H
Lu Y
Zhu S
Xu H
Zhao X
Yin H
Li D
Li H
Zhu Q
Publication year
Publication venue
International journal of biological sciences

External Links

Snippet

Avian leukosis virus (ALV) is oncogenic retrovirus that not only causes immunosuppression but also enhances the host's susceptibility to secondary infection. Exosomes play vital role in the signal transduction cascades that occur in response to viral infection. We want to explore …
Continue reading at pmc.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid

Similar Documents

Publication Publication Date Title
Ye et al. A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy
Miller et al. TOP2 synergizes with BAF chromatin remodeling for both resolution and formation of facultative heterochromatin
Wang et al. The complex exogenous RNA spectra in human plasma: an interface with human gut biota?
Potts et al. Using functional signature ontology (FUSION) to identify mechanisms of action for natural products
Smith et al. The little elongation complex regulates small nuclear RNA transcription
Jancewicz et al. PD-L1 overexpression, SWI/SNF complex deregulation, and profound transcriptomic changes characterize cancer-dependent exhaustion of persistently activated CD4+ T cells
Rekker et al. A two-cohort RNA-seq study reveals changes in endometrial and blood miRNome in fertile and infertile women
CA2914026A1 (en) Assays, methods and kits for analyzing sensitivity and resistance to anti-cancer drugs, predicting a cancer patient's prognosis, and personalized treatment strategies
Ye et al. Exosomes transmit viral genetic information and immune signals may cause immunosuppression and immune tolerance in ALV-J infected HD11 cells
Arribas et al. Transposable element exonization generates a reservoir of evolving and functional protein isoforms
Habbout et al. Implication of EZH2 in the pro-proliferative and apoptosis-resistant phenotype of pulmonary artery smooth muscle cells in PAH: a transcriptomic and proteomic approach
Wang et al. SATB1 regulates 3D genome architecture in T cells by constraining chromatin interactions surrounding CTCF-binding sites
Li et al. Chromatin state dynamics during NK cell activation
Au et al. MiR-1303 regulates mycobacteria induced autophagy by targeting Atg2B
Yu et al. Exosomal miR-205-5p improves endometrial receptivity by upregulating E-cadherin expression through ZEB1 inhibition
Dasgupta et al. Global analysis of contact-dependent human-to-mouse intercellular mRNA and lncRNA transfer in cell culture
Liu et al. MITA promotes macrophage proinflammatory polarization and its circRNA-related regulatory mechanism in recurrent miscarriage
Vad-Nielsen et al. Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells
Kopcho et al. SIV Infection regulates compartmentalization of circulating blood plasma mirnas within extracellular vesicles (EVs) and extracellular condensates (ECs) and decreases EV-Associated miRNA-128
Forester et al. Regulation of eIF4E guides a unique translational program to control erythroid maturation
Cesarini et al. ADAR2 protein is associated with overall survival in GBM patients and its decrease triggers the anchorage-independent cell growth signature
Mendes et al. Disclosing the interactome of leukemogenic NUP98-HOXA9 and SET-NUP214 fusion proteins using a proteomic approach
Kim et al. Precancerous cells initiate glioblastoma evolution and contribute to intratumoral heterogeneity
Valcárcel et al. Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing
Gong et al. Acetylation profiling by Iseq-Kac reveals insights into HSC aging and lineage decision